Scarica l'app Stockscreener
4.25
3.85%
-0.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.42
Aprire:
$4.4
Volume 24 ore:
2.31M
Relative Volume:
2.20
Capitalizzazione di mercato:
$814.72M
Reddito:
$12.99M
Utile/perdita netta:
$-74.39M
Rapporto P/E:
-9.6591
EPS:
-0.44
Flusso di cassa netto:
$-78.92M
1 W Prestazione:
-4.71%
1M Prestazione:
+21.78%
6M Prestazione:
+28.40%
1 anno Prestazione:
+2.66%
Intervallo 1D:
$4.175
$4.435
Intervallo di 1 settimana:
$4.175
$4.57
Portata 52W:
$2.705
$5.10
Arbutus Biopharma Corp Stock (ABUS) Company Profile
Nome
Arbutus Biopharma Corp
Settore
Industria
Telefono
604-419-3200
Indirizzo
701 VETERANS CIRCLE, WARMINSTER, PA
Confronta ABUS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABUS
Arbutus Biopharma Corp
|
4.25 | 847.31M | 12.99M | -74.39M | -78.92M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-02-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-02-25 | Iniziato | Jefferies | Hold |
| 2020-12-17 | Iniziato | H.C. Wainwright | Buy |
| 2020-07-27 | Ripresa | JMP Securities | Mkt Outperform |
| 2020-07-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-05-19 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2020-03-06 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2020-02-20 | Iniziato | Robert W. Baird | Outperform |
| 2020-02-05 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-10-07 | Reiterato | B. Riley FBR | Buy |
| 2019-10-04 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2018-10-16 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2018-10-15 | Aggiornamento | Wedbush | Underperform → Neutral |
| 2018-10-12 | Reiterato | Chardan Capital Markets | Buy |
| 2018-07-06 | Downgrade | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-03-19 | Ripresa | Chardan Capital Markets | Buy |
| 2018-03-19 | Downgrade | Wedbush | Outperform → Neutral |
| 2018-01-05 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-04-04 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2017-02-01 | Reiterato | Wedbush | Outperform |
| 2016-12-13 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2016-11-30 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
Mostra tutto
Arbutus Biopharma Corp Borsa (ABUS) Ultime notizie
What machine learning models say about Arbutus Biopharma Corporation2025 Key Lessons & AI Based Buy/Sell Signal Reports - newser.com
Building trade automation scripts for Arbutus Biopharma CorporationTake Profit & Weekly Breakout Watchlists - newser.com
Arbutus Biopharma Corporation stock volume spike explainedQuarterly Risk Review & High Win Rate Trade Alerts - newser.com
Is Arbutus Biopharma Corporation stock bottoming outLong Setup & Weekly Setup with ROI Potential - newser.com
what machine learning models say about arbutus biopharma corporationJuly 2025 PreEarnings & Risk Controlled Daily Plans - newser.com
Is Arbutus Biopharma Corporation reversing from oversold territoryOptions Play & Weekly Return Optimization Plans - newser.com
Using economic indicators to assess Arbutus Biopharma Corporation potential2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Aug Setups: Whats next for Arbutus Biopharma Corporation stockLong Setup & Weekly Breakout Watchlists - khodrobank.com
Reversal indicators forming on Arbutus Biopharma Corporation stockQuarterly Growth Report & Fast Entry Momentum Trade Alerts - newser.com
Analyzing drawdowns of Arbutus Biopharma Corporation with statistical toolsWeekly Trading Summary & Community Verified Trade Signals - newser.com
What MACD signals say about Arbutus Biopharma CorporationAnalyst Upgrade & Technical Pattern Based Signals - newser.com
Arbutus Biopharma Corporation $ABUS Shares Purchased by Goldman Sachs Group Inc. - MarketBeat
Aug Rallies: Is Arbutus Biopharma Corporation stock a top performer YTD2025 Price Action Summary & Technical Pattern Based Signals - خودرو بانک
RSI Check: Should I set a stop loss on RELYMarket Performance Report & Free Community Consensus Stock Picks - خودرو بانک
Arbutus: IP Drama With High Stakes (NASDAQ:ABUS) - Seeking Alpha
Fundamentals Check: What’s next for Arbutus Biopharma Corporation stockWeekly Volume Report & Risk Controlled Daily Trade Plans - khodrobank.com
Has Arbutus Biopharma Corporation formed a bullish divergenceCEO Change & Weekly Market Pulse Updates - newser.com
Published on: 2025-09-15 00:38:22 - newser.com
is arbutus biopharma corporation reversing from oversold territory2025 Short Interest & Daily Risk Controlled Trade Plans - newser.com
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Down 4.6%What's Next? - MarketBeat
Arbutus Biopharma Corporation stock retracement – recovery analysisQuarterly Growth Report & Expert Approved Momentum Ideas - newser.com
Arbutus Biopharma (NASDAQ:ABUS) Trading Up 6.4%Still a Buy? - MarketBeat
Is Arbutus Biopharma Corporation showing signs of accumulationQuarterly Portfolio Report & Expert Approved Momentum Ideas - Newser
Adage Capital Partners GP L.L.C. Cuts Stake in Arbutus Biopharma Corporation $ABUS - MarketBeat
What to expect from Arbutus Biopharma Corporation in the next 30 daysQuarterly Trade Summary & Daily Entry Point Alerts - Newser
Arbutus Biopharma (NASDAQ:ABUS) Hits New 1-Year HighStill a Buy? - MarketBeat
Relative strength of Arbutus Biopharma Corporation in sector analysisTrade Entry Report & Long-Term Investment Growth Plans - Newser
Combining price and volume data for Arbutus Biopharma CorporationDollar Strength & Reliable Intraday Trade Alerts - Newser
How institutional ownership impacts Arbutus Biopharma Corporation stockPortfolio Performance Summary & Weekly Market Pulse Alerts - Newser
Key resistance and support levels for Arbutus Biopharma CorporationJuly 2025 Selloffs & Short-Term High Return Ideas - Newser
Invesco Ltd. Has $487,000 Stock Holdings in Arbutus Biopharma Corporation $ABUS - MarketBeat
Two Seas Capital LP Acquires 725,000 Shares of Arbutus Biopharma Corporation $ABUS - MarketBeat
Chart based analysis of Arbutus Biopharma Corporation trendsWeekly Trend Summary & AI Powered Market Trend Analysis - Newser
Combining machine learning predictions for Arbutus Biopharma CorporationMarket Growth Review & AI Driven Price Forecasts - Newser
Is Arbutus Biopharma Corporation forming a bottoming baseWeekly Profit Report & Long-Term Capital Growth Ideas - Newser
Arbutus Biopharma Corp Azioni (ABUS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.43%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):